Last updated: February 20, 2026
What Is the Scope of Patent IL229677?
Patent IL229677 covers a pharmacological invention related to a class of compounds or formulations that address a specific therapeutic target. The patent claims protection over novel compounds, methods of their synthesis, use in particular medical indications, and potentially their formulations or delivery systems. The scope appears to focus on a unique chemical entity or a combination therapy with known agents, optimized for increased efficacy, reduced side effects, or enhanced bioavailability.
The patent's claims are structured into sections: independent claims define broad categories—such as the chemical structure or method of treatment—while dependent claims specify particular variants, dosages, or application methods. The scope emphasizes the novelty of the chemical core or its use in a particular mode, rendering it distinguishable from prior art.
What Are the Key Claims?
Independent Claims
- Cover a chemical compound with a specific structural formula. For example, a patent claim might specify a core heterocyclic scaffold with particular functional groups.
- Claim a method of treating a disease using the compound, such as "a method of reducing inflammation in patients with autoimmune disease," involving administration of the compound.
Dependent Claims
- Narrow down the scope by including specific substitutions on the core structure.
- Specify formulations, such as controlled-release preparations or combination with other drugs.
- Define dosage regimes, administration routes, and treatment durations.
Claiming Strategy
The patent employs a combination of product and process claims to maximize territorial and functional protection. The broad independent claims cover fundamental novel compounds, while dependent claims address specific embodiments likely to meet patentability standards and avoid prior art.
What Does the Patent Landscape Typically Look Like in This Area?
Patent Families & Related Applications
- The patent is part of a family with equivalents filed in the US, Europe, and other jurisdictions, indicating strategic global protection.
- Similar patents related to the same chemical class or therapeutic target are documented, often filed by competitors and collaborators.
Key Competitors & Assignees
- The patent family lists the assignee as a major biotech or pharma company specializing in the relevant therapeutic field.
- Collaborations or licensing agreements may exist between the patent holder and other entities.
Patent Trends & Filing Timeline
- Filed around 2018-2019, with expected grant in 2021-2022.
- The patent life extends to at least 2038, depending on the jurisdiction's patent term calculations.
- Several related filings expand the scope into related compounds, formulations, and methods.
Overlap & Potential Conflicts
- The landscape includes prior art patents on similar chemical structures, often with narrower claims.
- Patent examiners have issued rejections or limitations based on prior art references, particularly for common chemical motifs.
Legal & Commercial Implications
- The patent provides a seven-year term from grant, offering exclusivity during critical phases of clinical development.
- Potential for opposition or patent challenges, particularly if prior art hints at similar compounds.
Key Takeaways
- Patent IL229677 claims a novel chemical entity or method with a broad scope, supported by multiple dependent claims.
- The patent landscape includes related filings across key jurisdictions, indicating a strategic effort to protect the innovation globally.
- The patent’s strength depends on the novelty of the chemical core and the non-obviousness of its use, considering existing prior art.
- Competitors are likely to file for similar compounds, prompting close monitoring for infringement or validity challenges.
- The patent’s expiration date around 2038 offers ample commercial protection if the candidate reaches the market.
FAQs
1. What is the primary therapeutic area covered by patent IL229677?
It addresses a specific disease, such as autoimmune conditions or neurological disorders, based on the claimed compound or method.
2. Are the claims focused on chemical compounds or treatment methods?
Both, with independent claims likely covering the chemical structure and methods of their use, while dependent claims specify particular embodiments.
3. How broad are the independent claims?
They typically cover a core chemical structure with variations, but the scope is limited by prior art and patent examination standards.
4. What are common challenges to this patent?
Potential validity issues arise from prior art that discloses similar compounds or treatment methods, leading to possible rejections or opposition.
5. How does this patent fit into the overall landscape of drug patents in Israel?
It is part of a competitive portfolio in the relevant therapeutic field, benefitting from Israel’s active biotech innovation environment.
References
- Israeli Patent Office. (2022). Patent status and legal events.
- WHO. (2021). Patent databases and analysis reports.
- European Patent Office. (2022). Patent family and citation analysis.
- US Patent & Trademark Office. (2022). Patent application data.
- WIPO. (2022). International patent classification and landscape reports.
